NCT03166618View on ClinicalTrials.gov

Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

July 21, 2017

Study Completion Date

July 21, 2017

Conditions
Temple Hollowing
Interventions
DEVICE

Juvéderm® VOLUMA XC

Juvéderm® VOLUMA XC hyaluronic acid injectable gel

Trial Locations (1)

90069

Skin Care and Laser Physicians of Beverly Hills, Los Angeles

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT03166618 - Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing | Biotech Hunter | Biotech Hunter